HRID1481903

反应详情

EQUATION

反应方程式

REACTANTS

反应物

HCID7009590

未命名化合物

结构：COc1ccc2c(Br)cccc2c1CN1C(=O)[C@@H](NC(=O)[C@H](C)N(C)C(=O)OC(C)(C)C)CNc2ccccc21

HCID90220831

未命名化合物

2 次

结构：COc1ccc2ccccc2c1CN1C(=O)[C@@H](N)CNc2ccccc21.O=C(O)C(F)(F)F

HCID90221037

未命名化合物

PRODUCTS

生成物

结构：COc1ccc2ccccc2c1CN1C(=O)[C@@H](NC(=O)[C@H](C)N(C)C(=O)OC(C)(C)C)CNc2ccccc21

HCID90220896

未命名化合物

收率 73.2%

PROCEDURE

实验过程

In a similar manner to that described for the preparation of {(S)-1-[(S)-1-(5-bromo-2-methoxy-naphthalen-1-ylmethyl)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-ylcarbamoyl]-ethyl}-methyl-carbamic acid tert-butyl ester (Intermediate 12), (S)-3-amino-1-(2-methoxy-naphthalen-1-ylmethyl)-1,3,4,5-tetrahydro-benzo[b][1,4]diazepin-2-one trifluoroacetate salt (Step 1 above) (460 mg) and Boc-N-Me-Ala-OH (223.3 mg, 1.1 mmol) were converted to the title compound (390 mg, 73.2%) obtained as a white solid. LC-MS: 533 (M+H).

来源与证据

来源类型: Open Reaction Database
ORD 记录: ord-258b5d92561c467f88f9dd29235aa73d
来源数据集: uspto-grants-2016_08
DOI: 10.6084/m9.figshare.5104873.v1
专利: US09409888B2
来源说明: uspto-grants-2016_08

反应 SMILES

[C:1]([O:5][C:6](=[O:40])[N:7]([C@H:9]([C:11](=[O:39])[NH:12][C@@H:13]1[C:19](=[O:20])[N:18]([CH2:21][C:22]2[C:31]3[C:26](=[C:27](Br)[CH:28]=[CH:29][CH:30]=3)[CH:25]=[CH:24][C:23]=2[O:33][CH3:34])[C:17]2[CH:35]=[CH:36][CH:37]=[CH:38][C:16]=2[NH:15][CH2:14]1)[CH3:10])[CH3:8])([CH3:4])([CH3:3])[CH3:2].FC(F)(F)C(O)=O.N[C@@H]1C(=O)N(CC2C3C(=CC=CC=3)C=CC=2OC)C2C=CC=CC=2NC1.N(C(OC(C)(C)C)=O)(C)[C@H](C(O)=O)C>>[C:1]([O:5][C:6](=[O:40])[N:7]([C@H:9]([C:11](=[O:39])[NH:12][C@@H:13]1[C:19](=[O:20])[N:18]([CH2:21][C:22]2[C:31]3[C:26](=[CH:27][CH:28]=[CH:29][CH:30]=3)[CH:25]=[CH:24][C:23]=2[O:33][CH3:34])[C:17]2[CH:35]=[CH:36][CH:37]=[CH:38][C:16]=2[NH:15][CH2:14]1)[CH3:10])[CH3:8])([CH3:2])([CH3:3])[CH3:4]